(PharmaNewsWire.Com, January 09, 2017 ) According to the report "Global Antifungal Drugs Market published by Market Data Forecast, the global market is projected to reach USD 14.54 Billion by 2020, at a CAGR of 3.4% from 2015 to 2020
Antifungal Drugs Market are used for the treatment of fungal infections which occur commonly due to unhygienic environment. There are four major classes of antifungal drugs have been identified include azoles, echinocandins, allylamines, and polyenes. These classes prevent or treat fungal infections by targeting at molecular levels or specified developmental stages.
Growing focus of manufacturers to develop broad spectrum antifungal drugs target at specified molecular levels, advancements in the technologies from the past few years, rising healthcare expenditure, and increasing government involvements to support the development of better healthcare solutions are driving the growth of antifungal drugs market.
In addition, increasing use of over-the-counter antifungal drugs, growing awareness among public about fungal infections, rising adoption of advanced antifungal drugs, and global economic growth is also a significant factor responsible for the growth of antifungal drugs market.
The Antifungal Drugs Market is segmented is as following:
By Drug Type
By Therapeutic Indications
Other therapeutic indications
By Dosage Form
North America Antifungal Drugs Market
Europe Antifungal Drugs Market
Asia-Pacific Antifungal Drugs Market
Latin America Antifungal Drugs Market
Middle East and Africa Antifungal Drugs Market
The major companies operating in the global antifungal drugs market are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories.
The Antifungal Drugs market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of drug type, therapeutic indications, and dosage form along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Antifungal Drugs Market Segment:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: